We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company


Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

BioMérieux Acquires Antibiotic Susceptibility Test Firm Specific Diagnostics

By LabMedica International staff writers
Posted on 13 Apr 2022
Print article
Image: bioMérieux has entered into an agreement to acquire Specific Diagnostics (Photo courtesy of Pexels)
Image: bioMérieux has entered into an agreement to acquire Specific Diagnostics (Photo courtesy of Pexels)

Antimicrobial Resistance (AMR) is a global threat, with infections from antibiotic resistant pathogens being one of the leading causes of death around the world. For clinicians to save patients’ lives and rapidly optimize therapies, fast and accurate antimicrobial susceptibility test (AST) results and interpretation are critical. In addition to improving patient outcomes, rapid AST also reduces global AMR burdens by enabling the implementation of effective institutional Antimicrobial Stewardship (AMS) programs.

bioMérieux (Marcy-l'Étoile, France) has further strengthened its commitment to fight AMR with the acquisition of Specific Diagnostics (San Jose, CA, USA) which focuses on fast AST solution. Specific has developed a rapid AST system that delivers phenotypic AST directly from positive blood cultures. The SPECIFIC REVEAL Rapid AST system has been developed based on the company’s unique, patented metabolomic signature technology and offers an easy-to-use instrument with a targeted menu, small footprint, and modular design for adaptable throughput, well-suited to address the needs of clinical laboratories.

The SPECIFIC REVEAL Rapid AST system provides actionable results for Gram-negative bacteria directly from positive blood cultures in an average of five hours. This helps clinicians to address the challenge of bloodstream infections, allowing either timely de-escalation to a focused, more appropriate, and lower-cost therapy, or life-saving rapid escalation to more effective therapy where a multidrug-resistant (MDR) infection is present. SPECIFIC REVEAL seamlessly integrates with bioMérieux’s Sepsis Solution, including BACT/ALERT VIRTUO, VITEK MS PRIME, BIOFIRE BCID2, VIDAS PCT and VITEK2. With the addition of SPECIFIC REVEAL Rapid AST, the bioMérieux Sepsis Solution allows same-day AST results for Gram-negative bacteria to enable more targeted therapy and improve patient outcomes.

“This acquisition reinforces our long-standing commitment to sustain antibiotic efficacy for future generations,” said Alexandre Mérieux, Chairman and Chief Executive Officer, bioMérieux. “With the addition of Specific Diagnostics’ REVEAL Rapid AST system into our microbiology portfolio, bioMérieux further supports clinicians and laboratories in further improving patient outcomes and enhancing antimicrobial stewardship, leveraging our extensive distribution network.”

Related Links:
Specific Diagnostics

Gold Supplier
Automatic Hematology Analyzer
Benchtop Centrifuge & Vortexer
High-Throughput Nucleic Acid Extractor
Stream SP96

Print article


Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: Guidance UTI provides personalized results in less than one day from receipt at lab (Photo courtesy of Pathnostics)

Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture

Complicated urinary tract infections (cUTIs) are a significant burden on individual health and healthcare resources that must be diagnosed and treated early and accurately to reduce the risk of poor outcomes.... Read more


view channel
Image: The CS-2500 analyzer features pre-analytic sample checks and four detection methods simultaneously on a single platform – coagulation end-point, chromogenic kinetic analysis, turbidimetric immunoassay and automated platelet aggregation (Photo courtesy of Sysmex)

Microvascular/Endothelial Dysfunction Contributes to Post-COVID Syndrome Pathogenesis

Post-COVID syndrome (PCS) or Long-COVID is an increasingly recognized complication of acute SARS-CoV-2 infection, characterized by persistent fatigue, reduced exercise tolerance chest pain, shortness of... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.